Inactive Instrument
Sector ValiRx Plc London S.E.
Stocks
GB00B23N9136
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - GBX | - |
|
| 07-17 | Valirx plc Announces Termination of Catherine Jane Tralau-Stewart from Director Role, Effective July 17, 2026 | CI |
| 06-22 | EARNINGS AND TRADING: ValiRx profit slides; Ukrproduct loss narrows | AN |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +8.49% | +20.55% | +27.88% | +44.96% | +70.81% | +70.77% | +103.07% | +8.43% | - | 68.12B | |
| +1.25% | +2.44% | -4.22% | +13.77% | +6.47% | +34.27% | +68.92% | +182.56% | +5,511.76% | 55.18B | |
| -1.09% | +32.96% | +10.86% | +29.35% | -24.67% | +19.67% | +509.20% | +432.93% | +1,011.96% | 28.63B | |
| +10.83% | +18.38% | +23.75% | +40.42% | +45.87% | +56.20% | +4.58% | -63.46% | - | 23.99B | |
| +2.72% | +3.41% | +0.74% | -0.48% | -1.61% | -16.11% | -12.04% | -79.06% | - | 23.53B | |
| +6.50% | +7.56% | +3.58% | +21.78% | -1.38% | +44.65% | -22.01% | -31.00% | +62.12% | 18.45B | |
| +6.20% | +11.51% | +13.58% | +20.64% | +37.56% | +33.87% | +666.34% | - | - | 16.44B | |
| -3.88% | +16.98% | -3.50% | +89.99% | +192.66% | +199.30% | +350.94% | +1,505.09% | +736.41% | 15.83B | |
| +3.58% | +1.96% | -5.31% | +12.27% | +23.36% | +43.35% | +162.22% | +208.09% | +397.42% | 13.4B | |
| +2.12% | +3.54% | +4.35% | +20.58% | +32.02% | +433.80% | +202.14% | +39.61% | +1,271.67% | 12.38B | |
| -0.06% | +9.14% | -8.92% | 0.00% | -12.42% | +47.53% | +202.28% | +483.77% | +6,549.80% | 11.78B | |
| +4.11% | +6.44% | +5.65% | -25.37% | -11.50% | -37.66% | +190.28% | +108.77% | - | 11.74B | |
| +3.10% | +7.22% | -9.82% | -22.79% | -20.18% | -51.29% | +619.59% | +73.20% | +108.36% | 11.14B | |
| -5.67% | -0.48% | -10.82% | -0.20% | +20.81% | +125.04% | +141.38% | +140.70% | +526.10% | 10.67B | |
| +8.49% | +5.50% | +5.25% | -11.72% | +19.79% | +33.31% | +121.44% | -11.76% | - | 9.26B | |
| +1.44% | +6.69% | +6.24% | +39.80% | +220.24% | +592.02% | +745.37% | -35.34% | -11.47% | 9.25B | |
| +0.19% | +0.67% | +0.55% | +124.33% | +80.62% | +213.15% | +404.08% | +398.10% | - | 8.92B | |
| -1.39% | +7.38% | -2.94% | +9.55% | +25.86% | +94.21% | +23.68% | +137.51% | - | 8.64B | |
| +4.37% | +6.56% | -13.87% | -10.22% | +285.86% | +213.11% | +357.49% | -31.42% | - | 8.1B | |
| Average | +2.70% | +8.31% | +2.26% | +20.88% | +52.11% | +113.11% | +254.68% | +192.60% | +1,616.41% | 19.23B | |
| Weighted average by Cap. | +3.59% | +10.92% | +6.82% | +24.68% | +41.27% | +81.65% | +201.83% | +170.58% | +2,414.85% |
- Stock Market
- Stocks
- VAL Stock
- Stock
- Sector ValiRx Plc
Select your edition
All financial news and data tailored to specific country editions
